AMGN vs DGX
By Alex · Tickerpine
Amgen Inc. vs Quest Diagnostics Incorporated, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | AMGN | DGX |
|---|---|---|
| Price | $416.18 | $237.77 |
| Market cap | $225.15B | $26.24B |
| P/E ratio | 25.7 | 25.2 |
| ROE | 91.47% | 14.60% |
| Profit margin | 22.95% | 9.19% |
| Revenue growth | 9.50% | 10.20% |
| Dividend yield | 2.43% | 1.45% |
| Beta | 0.41 | 0.55 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
AMGN vs DGX in plain English
- AMGN is the bigger company — about 8.6× the market cap of DGX.
- DGX is cheaper on earnings (P/E 25.2 vs 25.7).
- AMGN earns a higher return on equity (91% vs 15%).
- DGX is growing revenue faster (10% vs 10%).
- AMGN has the higher dividend yield (2.43% vs 1.45%).
How would $1,000 have done in each?
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
DGX return calculator
See what $1,000 in Quest Diagnostics Incorporated would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.